{"id":27979,"date":"2024-10-29T16:30:45","date_gmt":"2024-10-29T15:30:45","guid":{"rendered":"https:\/\/ggba.swiss\/ikerian-secures-usd-8-million-and-a-strategic-partnership-with-sanoptis\/"},"modified":"2024-10-29T16:33:17","modified_gmt":"2024-10-29T15:33:17","slug":"ikerian-decroche-usd-8-millions-et-un-partenariat-strategique-avec-sanoptis","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/ikerian-decroche-usd-8-millions-et-un-partenariat-strategique-avec-sanoptis\/","title":{"rendered":"Ikerian d\u00e9croche USD 8 millions et un partenariat strat\u00e9gique avec Sanoptis"},"content":{"rendered":"\n<p>Ikerian AG, la soci\u00e9t\u00e9 m\u00e8re de <a href=\"https:\/\/www.retinai.com\/\">RetinAI<\/a>, a lev\u00e9 USD 8 millions lors de la premi\u00e8re tranche de son tour de table de s\u00e9rie B, men\u00e9 par la soci\u00e9t\u00e9 <a href=\"https:\/\/sanoptis.com\/\">Sanoptis<\/a>. Le financement sera utilis\u00e9 pour poursuivre le d\u00e9veloppement de la plateforme Discovery CONNECT d&rsquo;Ikerian, une solution clinique con\u00e7ue pour rationaliser et automatiser la gestion des donn\u00e9es d&rsquo;imagerie dans les cliniques d&rsquo;ophtalmologie. Parall\u00e8lement \u00e0 cet investissement, Sanoptis &#8211; un r\u00e9seau europ\u00e9en d&rsquo;ophtalmologie de premier plan comptant plus de 420 cliniques &#8211; a conclu un accord commercial avec Ikerian pour int\u00e9grer la plateforme pilot\u00e9e par l&rsquo;IA de RetinAI Discovery dans ses cliniques. Cela permettra de soutenir la gestion des donn\u00e9es \u00e0 grande \u00e9chelle et d&rsquo;am\u00e9liorer les soins prodigu\u00e9s aux patients.<\/p>\n\n\n\n<p>Fond\u00e9es en 2017, Ikerian et sa filiale RetinAI sont \u00e0 l&rsquo;avant-garde des solutions aliment\u00e9es par l&rsquo;IA pour l&rsquo;ophtalmologie. La plateforme Discovery de RetinAI, qui a d\u00e9j\u00e0 re\u00e7u les certifications 510(k) et CE de la FDA, fournit une analyse avanc\u00e9e des donn\u00e9es et des images aliment\u00e9es par l&rsquo;apprentissage automatique. Gr\u00e2ce \u00e0 des partenariats avec de grandes soci\u00e9t\u00e9s de soins de sant\u00e9 telles que Boehringer Ingelheim, Novartis et J&amp;J, la plateforme de RetinAI s&rsquo;est progressivement impos\u00e9e comme un outil essentiel pour la gestion des flux de travail cliniques et le transfert de donn\u00e9es dans le domaine de l&rsquo;ophtalmologie.<\/p>\n\n\n\n<p>Sur cette base, les nouveaux fonds permettront d&rsquo;acc\u00e9l\u00e9rer le d\u00e9veloppement de Discovery CONNECT, un logiciel innovant con\u00e7u pour transf\u00e9rer de mani\u00e8re s\u00e9curis\u00e9e et efficace les donn\u00e9es d&rsquo;imagerie \u00e0 travers les r\u00e9seaux cliniques. Discovery CONNECT, dont la sortie est pr\u00e9vue pour le d\u00e9but de 2025, vise \u00e0 simplifier les flux de travail cliniques, \u00e0 anonymiser les donn\u00e9es et \u00e0 r\u00e9duire le traitement manuel afin de soutenir la production de preuves dans le monde r\u00e9el et d&rsquo;optimiser le recrutement d&rsquo;essais cliniques.<\/p>\n\n\n\n<p>Cet investissement fait suite \u00e0 un <a href=\"https:\/\/ggba.swiss\/fr\/ikerian-societe-mere-de-retinai-leve-usd-618-millions-pour-des-avancees-medicales-basees-sur-lia\/\">tour d&rsquo;extension de s\u00e9rie A de USD 6,18 millions plus t\u00f4t en 2024<\/a>, qui a permis \u00e0 Ikerian d&rsquo;\u00e9tendre la base de donn\u00e9es Real-World Evidence (RWE) de RetinAI et d&rsquo;am\u00e9liorer ses capacit\u00e9s d&rsquo;IA en ophtalmologie et dans les maladies neurod\u00e9g\u00e9n\u00e9ratives. La soci\u00e9t\u00e9 cherche maintenant \u00e0 se d\u00e9velopper dans de nouveaux domaines, notamment l&rsquo;oculomique, avec des applications dans les maladies vasculaires et les maladies rares.<\/p>\n\n\n\n<p>Dans le cadre de cet accord commercial, Sanoptis distribuera la plateforme Discovery \u00e0 des cliniques s\u00e9lectionn\u00e9es au sein de son r\u00e9seau. \u00ab Ce partenariat avec Ikerian marque une \u00e9tape importante dans la transformation de la pratique de l&rsquo;ophtalmologie \u00bb, a comment\u00e9 Volker Wendel, CEO de Sanoptis. \u00ab Ensemble, nous visons \u00e0 donner plus de pouvoir aux cliniciens, \u00e0 am\u00e9liorer l&rsquo;efficacit\u00e9 du flux de travail et, en fin de compte, \u00e0 am\u00e9liorer les r\u00e9sultats pour les patients. \u00bb<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ikerian a lev\u00e9 USD 8 millions en financement de s\u00e9rie B pour faire progresser Discovery CONNECT, une plateforme qui optimise la gestion des donn\u00e9es dans les cliniques d&rsquo;ophtalmologie. L&rsquo;investisseur principal, Sanoptis, a conclu un partenariat strat\u00e9gique pour distribuer la plateforme \u00e0 travers son r\u00e9seau europ\u00e9en.<\/p>\n","protected":false},"author":6,"featured_media":27976,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1179,1180,1148,1251,1171],"class_list":["post-27979","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-artificial-intelligence-fr-2","tag-digital-health-fr-2","tag-financing-fr-2","tag-imaging-fr-2","tag-pharma-fr-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ikerian d\u00e9croche USD 8 millions et un partenariat avec Sanoptis<\/title>\n<meta name=\"description\" content=\"Ikerian a lev\u00e9 USD 8M pour faire progresser Discovery CONNECT, sa plateforme de gestion des donn\u00e9es dans les cliniques d&#039;ophtalmologie.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/ikerian-decroche-usd-8-millions-et-un-partenariat-strategique-avec-sanoptis\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ikerian d\u00e9croche USD 8 millions et un partenariat avec Sanoptis\" \/>\n<meta property=\"og:description\" content=\"Ikerian a lev\u00e9 USD 8M pour faire progresser Discovery CONNECT, sa plateforme de gestion des donn\u00e9es dans les cliniques d&#039;ophtalmologie.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/ikerian-decroche-usd-8-millions-et-un-partenariat-strategique-avec-sanoptis\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-29T15:30:45+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-29T15:33:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Ikerian-Sanoptis-1180x811-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1178\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/ikerian-decroche-usd-8-millions-et-un-partenariat-strategique-avec-sanoptis\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/ikerian-decroche-usd-8-millions-et-un-partenariat-strategique-avec-sanoptis\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"Ikerian d\u00e9croche USD 8 millions et un partenariat strat\u00e9gique avec Sanoptis\",\"datePublished\":\"2024-10-29T15:30:45+00:00\",\"dateModified\":\"2024-10-29T15:33:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/ikerian-decroche-usd-8-millions-et-un-partenariat-strategique-avec-sanoptis\/\"},\"wordCount\":511,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/ikerian-decroche-usd-8-millions-et-un-partenariat-strategique-avec-sanoptis\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Ikerian-Sanoptis-1180x811-1.jpg\",\"keywords\":[\"Artificial Intelligence\",\"Digital Health\",\"Financing\",\"Imaging\",\"Pharma\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/fr\/ikerian-decroche-usd-8-millions-et-un-partenariat-strategique-avec-sanoptis\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/ikerian-decroche-usd-8-millions-et-un-partenariat-strategique-avec-sanoptis\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/ikerian-decroche-usd-8-millions-et-un-partenariat-strategique-avec-sanoptis\/\",\"name\":\"Ikerian d\u00e9croche USD 8 millions et un partenariat avec Sanoptis\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/ikerian-decroche-usd-8-millions-et-un-partenariat-strategique-avec-sanoptis\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/ikerian-decroche-usd-8-millions-et-un-partenariat-strategique-avec-sanoptis\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Ikerian-Sanoptis-1180x811-1.jpg\",\"datePublished\":\"2024-10-29T15:30:45+00:00\",\"dateModified\":\"2024-10-29T15:33:17+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"Ikerian a lev\u00e9 USD 8M pour faire progresser Discovery CONNECT, sa plateforme de gestion des donn\u00e9es dans les cliniques d'ophtalmologie.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/ikerian-decroche-usd-8-millions-et-un-partenariat-strategique-avec-sanoptis\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/ikerian-decroche-usd-8-millions-et-un-partenariat-strategique-avec-sanoptis\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/ikerian-decroche-usd-8-millions-et-un-partenariat-strategique-avec-sanoptis\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Ikerian-Sanoptis-1180x811-1.jpg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Ikerian-Sanoptis-1180x811-1.jpg\",\"width\":1178,\"height\":811,\"caption\":\"Dans la recherche et la pratique clinique, le manque de structure et d'accessibilit\u00e9 des donn\u00e9es limite l'acquisition de connaissances pr\u00e9cieuses n\u00e9cessaires \u00e0 la prise de d\u00e9cision. Ikerian a d\u00e9velopp\u00e9 une plateforme de gestion des donn\u00e9es aliment\u00e9e par l'IA pour traiter efficacement les donn\u00e9es visuelles \u00e0 grande \u00e9chelle \u00e0 travers de multiples sources de donn\u00e9es. | \u00a9 Ikerian\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/ikerian-decroche-usd-8-millions-et-un-partenariat-strategique-avec-sanoptis\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ikerian d\u00e9croche USD 8 millions et un partenariat strat\u00e9gique avec Sanoptis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ikerian d\u00e9croche USD 8 millions et un partenariat avec Sanoptis","description":"Ikerian a lev\u00e9 USD 8M pour faire progresser Discovery CONNECT, sa plateforme de gestion des donn\u00e9es dans les cliniques d'ophtalmologie.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/ikerian-decroche-usd-8-millions-et-un-partenariat-strategique-avec-sanoptis\/","og_locale":"fr_FR","og_type":"article","og_title":"Ikerian d\u00e9croche USD 8 millions et un partenariat avec Sanoptis","og_description":"Ikerian a lev\u00e9 USD 8M pour faire progresser Discovery CONNECT, sa plateforme de gestion des donn\u00e9es dans les cliniques d'ophtalmologie.","og_url":"https:\/\/ggba.swiss\/fr\/ikerian-decroche-usd-8-millions-et-un-partenariat-strategique-avec-sanoptis\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2024-10-29T15:30:45+00:00","article_modified_time":"2024-10-29T15:33:17+00:00","og_image":[{"width":1178,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Ikerian-Sanoptis-1180x811-1.jpg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Pierre-Yves Oehrli","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/ikerian-decroche-usd-8-millions-et-un-partenariat-strategique-avec-sanoptis\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/ikerian-decroche-usd-8-millions-et-un-partenariat-strategique-avec-sanoptis\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"Ikerian d\u00e9croche USD 8 millions et un partenariat strat\u00e9gique avec Sanoptis","datePublished":"2024-10-29T15:30:45+00:00","dateModified":"2024-10-29T15:33:17+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/ikerian-decroche-usd-8-millions-et-un-partenariat-strategique-avec-sanoptis\/"},"wordCount":511,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/fr\/ikerian-decroche-usd-8-millions-et-un-partenariat-strategique-avec-sanoptis\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Ikerian-Sanoptis-1180x811-1.jpg","keywords":["Artificial Intelligence","Digital Health","Financing","Imaging","Pharma"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/fr\/ikerian-decroche-usd-8-millions-et-un-partenariat-strategique-avec-sanoptis\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/ikerian-decroche-usd-8-millions-et-un-partenariat-strategique-avec-sanoptis\/","url":"https:\/\/ggba.swiss\/fr\/ikerian-decroche-usd-8-millions-et-un-partenariat-strategique-avec-sanoptis\/","name":"Ikerian d\u00e9croche USD 8 millions et un partenariat avec Sanoptis","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/ikerian-decroche-usd-8-millions-et-un-partenariat-strategique-avec-sanoptis\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/ikerian-decroche-usd-8-millions-et-un-partenariat-strategique-avec-sanoptis\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Ikerian-Sanoptis-1180x811-1.jpg","datePublished":"2024-10-29T15:30:45+00:00","dateModified":"2024-10-29T15:33:17+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"Ikerian a lev\u00e9 USD 8M pour faire progresser Discovery CONNECT, sa plateforme de gestion des donn\u00e9es dans les cliniques d'ophtalmologie.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/ikerian-decroche-usd-8-millions-et-un-partenariat-strategique-avec-sanoptis\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/ikerian-decroche-usd-8-millions-et-un-partenariat-strategique-avec-sanoptis\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/ikerian-decroche-usd-8-millions-et-un-partenariat-strategique-avec-sanoptis\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Ikerian-Sanoptis-1180x811-1.jpg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Ikerian-Sanoptis-1180x811-1.jpg","width":1178,"height":811,"caption":"Dans la recherche et la pratique clinique, le manque de structure et d'accessibilit\u00e9 des donn\u00e9es limite l'acquisition de connaissances pr\u00e9cieuses n\u00e9cessaires \u00e0 la prise de d\u00e9cision. Ikerian a d\u00e9velopp\u00e9 une plateforme de gestion des donn\u00e9es aliment\u00e9e par l'IA pour traiter efficacement les donn\u00e9es visuelles \u00e0 grande \u00e9chelle \u00e0 travers de multiples sources de donn\u00e9es. | \u00a9 Ikerian"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/ikerian-decroche-usd-8-millions-et-un-partenariat-strategique-avec-sanoptis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"Ikerian d\u00e9croche USD 8 millions et un partenariat strat\u00e9gique avec Sanoptis"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/27979","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=27979"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/27979\/revisions"}],"predecessor-version":[{"id":27981,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/27979\/revisions\/27981"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/27976"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=27979"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=27979"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=27979"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}